BROCHURES & HANDOUTS

Parents and patients have many questions.They’ll remember to ask you some of them. But they won’t remember many of them until after they’ve left the office.

 

Our patient education materials are designed to reinforce your instructions. Written in patient-friendly language, these brochures and handouts can help parents and patients remember what you told them—and answer the questions they forgot to ask.

Brochures & Handouts: Tracking Patient Symptoms

The Medication Guide and worksheets help your patients understand CONCERTA while you gain valuable data to optimize dosage.

Medication Guide

 

Symptom Tracking Sheets

Each sheet includes a series of questions that will help gauge your patient’s progress with various symptoms of ADHD.

 

Patients new to CONCERTA

If your patient has begun taking CONCERTA within the last 30 days, this Symptom Tracking Sheet helps determine the most appropriate dose.

Initial Symptom Tracking Worksheet

 

Current CONCERTA patients

If your patient has been taking CONCERTA for more than 30 days, this Symptom Tracking Sheet helps determine the most appropriate dose.

Continuing Symptom Tracking Worksheet

 

Spanish Consumer Brochures

Please click on the links provided to download an English version of our Spanish consumer overview brochure and Juvenile kit.

 



These documents are provided in Portable Document Format (PDF).
To view and print these documents you need the free Adobe Acrobat Reader®. If you do not have it, click here to download the free reader.

CONCERTA® is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).

IMPORTANT SAFETY INFORMATION

CONCERTA® should not be taken by patients with: allergies to methylphenidate or other ingredients in CONCERTA®; significant anxiety, tension, or agitation; glaucoma; Tourette's syndrome, tics, or family history of Tourette's syndrome; current or recent use of monoamine oxidase inhibitors (MAOIs). Children under 6 years of age should not take CONCERTA.®

Abuse of methylphenidate may lead to dependence. CONCERTA® should not be used in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, other serious cardiac problems, or patients with pre-existing severe gastrointestinal narrowing. Use with caution in patients with hypertension and other cardiovascular conditions, psychosis, bipolar disorder, and history of seizures/EEG abnormalities. Stimulants may cause new psychotic or manic symptoms; discontinuation of treatment may be appropriate. Aggressive behavior or hostility should be monitored in patients beginning ADHD treatment. Methylphenidate may produce difficulties with visual accommodation and blurring of vision. Hematologic monitoring is advised during prolonged therapy. Growth should be monitored during treatment with stimulants, and patients who are not growing or gaining height or weight as expected may need to have their treatment interrupted.

The most common adverse reaction (>5%) reported in children and adolescents was abdominal pain upper. The most common adverse reactions (>10%) reported in adults were dry mouth, nausea, decreased appetite, headache, and insomnia.

Please see full U.S. Prescribing Information

© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2010. All rights reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy. This site is published by McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. which is solely responsible for its contents.

This information is intended for the use of our customers and healthcare professionals in the United States and Puerto Rico only. McNeil Pediatrics recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may be not be appropriate for use outside the United States and Puerto Rico.

CONCERTA® and OROS® are registered trademarks of ALZA Corporation © Ortho-McNeil-Janssen Pharmaceuticals, Inc. Titusville, NJ, USA. All rights reserved.

McNeil Pediatrics Logo



Last Modified Date: Oct 08 2008 at 14:43:26 EDT